25739-59-7

Usage

Uses

Used in Sports Nutrition:
Propanamide, 2-amino-3-hydroxyis used as a dietary supplement for enhancing exercise performance and delaying muscle fatigue. The increased muscle carnosine levels resulting from beta-alanine supplementation can improve physical endurance and reduce muscle soreness during high-intensity workouts.
Used in Pharmaceutical Industry:
Propanamide, 2-amino-3-hydroxyis used as a potential therapeutic agent for managing conditions such as diabetes and Parkinson's disease. Its antioxidant properties and ability to increase muscle carnosine levels may contribute to the management and treatment of these conditions.
Used in Cosmetics Industry:
Propanamide, 2-amino-3-hydroxyis used as an ingredient in cosmetic products for its antioxidant properties. It may help protect the skin from oxidative stress and support skin health by maintaining the integrity of collagen and elastin fibers.

Upstream product

• 2104-89-4 Ser-OMe 
• 85472-28-2 N^α-Benzyloxycarbonyl-serin-amid 
• 125310-61-4 2-amino-3-hydroxypropionitrile 
• 5619-04-5 methyl 2-amino-3-hydroxypropanoate hydrochloride 

Relevant academic research and scientific papers

2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

The invention provides certain 2-pyridyl carboxamide-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A and B are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.

Derivatives of antibiotic GE2270 factors C2a, D2 and E

Mono- or di-substituted derivatives of GE2270 factors C2a, D2 and E of general formula (I), wherein W represents a moiety of formula (a), (b) or (c), R1 and R2 representing a variety of substituents, X1 is methyl, X2 is a --CH2 --W1 moiety and X3 is methylamino or amino, or X1 is a --CH2 --W1 moiety, X2 is methoxymethylene and X3 is methylamino, with the proviso that when X3 is amino, then W must be 2-(aminocarbonyl)-pyrrolidinyl; with the further proviso that when W is 2-(aminocarbonyl)-pyrrolidinyl, then W1 cannot be hydroxy; and the pharmaceutically acceptable salts thereof. The mono- or di-substituted derivatives of antibiotic GE 2270 of formula (I) are antimicrobial agents mainly active against gram positive bacteria. STR1

Carbamoyl substituted heterocycles

This invention relates to carbamoyl substituted heterocycles which are ω-phenyl-ω-(3-pyridyl)-ω-alkenoic acid derivatives bearing a carbamoyl substituted oxazolyl or oxazolinyl group on the phenyl ring and which demonstrate utility for thromboxane receptor antagonism and/or thromboxane synthase inhibition, as well as pharmaceutical formulations containing them, methods for their use, and processes and intermediates for their preparation.

Preparation of substituted alkenoic acids

This invention relates to a highly selective process for preparation of E-ω-phenyl-ω-(3-pyridyl)-ω-alkenoic acid derivatives bearing a carbamoyl substituted oxazolyl or oxazolinyl group on the phenyl ring which demonstrate utility for thromboxane receptor antagonism and/or thromboxane synthase inhibition, as well as to intermediates therefor.

PREPARATION OF SUBSTITUTED ALKENOIC ACIDS

This invention relates to a highly selective process for preparation of E-ω-phenyl-ω-(3-pyridyl)-ω-alkenoic acid derivatives bearing a carbamoyl substituted oxazolyl or oxazolinyl group on the phenyl ring which demonstrate utility for thromboxane receptor antagonism and/or thromboxane synthase inhibition, as well as to intermediates therefor.

Carbamoyl substituted oxazoles as thromboxane receptor antagonists

This invention relates to carbamoyl substituted heterocycles which are ω-phenyl-ω-(3-pyridyl)-ω-alkenoic acid derivatives bearing a carbamoyl substituted oxazolyl or oxazolinyl group on the phenyl ring and which demonstrate utility for thromboxane receptor antagonism and/or thromboxane synthase inhibition, as well as pharmaceutical formulations containing them, methods for their use, and processes and intermediates for their preparation.